Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADAG Adagene

Post-Mkt 09-10 19:30:15 EDT

3.31

+0.04

+1.22%

盘后3.25

-0.06-1.81%

19:30 EDT

High3.55	Low3.20	Vol224.59K
Open3.54	D1 Closing3.27	Amplitude10.76%
Mkt Cap222.24M	Tradable Cap194.88M	Total Shares67.14M
T/O740.15K	T/O Rate0.38%	Tradable Shares58.88M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ADAG","market":"US","secType":"STK","nameCN":"Adagene","latestPrice":3.31,"timestamp":1789070400000,"preClose":3.27,"halted":0,"volume":224589,"hourTrading":{"tag":"盘后","latestPrice":3.25,"preClose":3.31,"latestTime":"19:30 EDT","volume":801,"amount":2629.5831153,"timestamp":1789083005902,"change":-0.06,"changeRate":-0.018127,"amplitude":0.090634},"delay":0,"changeRate":0.012232415902140683,"floatShares":58875900,"shares":67143300,"eps":-0.3773,"marketStatus":"Post-Mkt","change":0.04,"latestTime":"09-10 19:30:15 EDT","open":3.54,"high":3.5519,"low":3.2,"amount":740154.6325029,"amplitude":0.107615,"askPrice":3.96,"askSize":100,"bidPrice":2.98,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.3773,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"adrRate":1.25,"listingDate":1612846800000,"exchange":"NASDAQ","adjPreClose":3.27,"preHourTrading":{"tag":"盘前","latestPrice":3.58,"preClose":3.27,"latestTime":"09:29 EDT","volume":497,"amount":1776.5466782,"timestamp":1789046999844,"change":0.31,"changeRate":0.094801,"amplitude":0.11315},"postHourTrading":{"tag":"盘后","latestPrice":3.25,"preClose":3.31,"latestTime":"19:30 EDT","volume":801,"amount":2629.5831153,"timestamp":1789083005902,"change":-0.06,"changeRate":-0.018127,"amplitude":0.090634},"volumeRatio":1.479303},"requestUrl":"/m/hq/s/ADAG/wiki","defaultTab":"wiki","newsList":[{"id":"2666594701","title":"Adagene’s Platform Partnerships and Muzastotug Catalysts Support Buy Rating, Price Target Unchanged at $8","url":"https://stock-news.laohu8.com/highlight/detail?id=2666594701","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666594701?lang=en_us&edition=fundamental","pubTime":"2026-09-10 23:05","pubTimestamp":1789052723,"startTime":"0","endTime":"0","summary":"Charles Zhu, an analyst from LifeSci Capital, maintained the Buy rating on Adagene. The associated price target remains the same with $8.00. Charle...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/adagenes-platform-partnerships-and-muzastotug-catalysts-support-buy-rating-price-target-unchanged-at-8-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/adagenes-platform-partnerships-and-muzastotug-catalysts-support-buy-rating-price-target-unchanged-at-8-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666759800","title":"Adagene, Third Arc Bio Expand SAFEbody Masked CD3 T-Cell Engager Collaboration with First Lead Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=2666759800","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666759800?lang=en_us&edition=fundamental","pubTime":"2026-09-10 20:04","pubTimestamp":1789041845,"startTime":"0","endTime":"0","summary":"Adagene, Third Arc Bio expand SAFEbody masked CD3 T-cell engager collaboration with first lead pickAdagene broadened its strategic licensing collaboration with Third Arc Bio after Third Arc selected t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260910:nNDLbVgK8M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666359817","title":"Adagene Initiated at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2666359817","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666359817?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:57","pubTimestamp":1789041420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ADAG/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956773","title":"Chardan Initiates Adagene at Buy With $9 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956773","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666956773?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:59","pubTimestamp":1789037991,"startTime":"0","endTime":"0","summary":"Adagene (ADAG) has an average rating of buy and mean price target of $10.49, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666256766","title":"Adagene initiated with a Buy at Chardan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666256766","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666256766?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:35","pubTimestamp":1789036521,"startTime":"0","endTime":"0","summary":"Chardan initiated coverage of Adagene (ADAG) with a Buy rating and $9 price target Adagene is a clinical stage company developing its lead asset, m...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/adagene-initiated-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/adagene-initiated-with-a-buy-at-chardan-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666953663","title":"Adagene Receives Milestone Payment From Exelixis","url":"https://stock-news.laohu8.com/highlight/detail?id=2666953663","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666953663?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:42","pubTimestamp":1788961358,"startTime":"0","endTime":"0","summary":"Adagene  said Wednesday that a preclinical milestone for drug candidate XB404 triggered a $2 million payment from licensing partner Exelixis .The selection of candidates for a separate antibody-drug program generated an additional payment, the company said.The company remains eligible for future development and commercialization milestones along with royalties on net product sales, Adagene said.Shares of Adagene were down 2% in Wednesday trading.Price: 3.41, Change: -0.08, Percent Change: -2.29","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["EXEL","BK4139","ADAG","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533954","title":"Adagene Secures Milestone Payments in Exelixis SAFEbody ADC Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533954","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533954?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:34","pubTimestamp":1788957298,"startTime":"0","endTime":"0","summary":"An update from Adagene ( ($ADAG) ) is now available. On September 9, 2026, Adagene Inc. reported achieving a preclinical milestone in its collabora...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/adagene-secures-milestone-payments-in-exelixis-safebody-adc-collaboration?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/adagene-secures-milestone-payments-in-exelixis-safebody-adc-collaboration?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","BK4139","EXEL","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666651538","title":"Adagene Receives USD 2 Million Exelixis Milestone Payment for SAFEbody ADC Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666651538","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666651538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:03","pubTimestamp":1788955414,"startTime":"0","endTime":"0","summary":"Adagene receives USD 2 million Exelixis milestone payment for SAFEbody ADC programAdagene reported a USD 2 million milestone payment from Exelixis tied to a preclinical milestone for SAFEbody ADC cand","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL3Bn9SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014021.USD","IE00BQXX3F31.USD","LU2095319765.USD","IE00BQXX3D17.EUR","BK4139","BK4112","IE00BGHQF748.EUR","BK4532","NDAQ","SG9999014013.SGD","IE00BKPKM429.USD","EXEL","IE00B3QW5Z07.USD","BK4585","IE00BQXX3C00.GBP","BK4588","LU2210149790.SGD","IE00BN0W2W23.USD","BCDF","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BN0W2V16.EUR","LU0314104364.USD","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666385795","title":"Adagene Hits Preclinical Milestone for Exelixis-Partnered XB404 SAFEbody ADC, Triggers $2 Million Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666385795","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666385795?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:02","pubTimestamp":1788955351,"startTime":"0","endTime":"0","summary":"Adagene hits preclinical milestone for Exelixis-partnered XB404 SAFEbody ADC, triggers $2 million paymentAdagene hit a preclinical milestone for Exelixis-partnered XB404, a SAFEbody-masked ADC targeti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL4Qc0yx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","EXEL","ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533137","title":"Adagene Achieves Milestone in Collaboration with Exelixis for Advancement of SAFEbody® Antibody-Drug Conjugate Candidates","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533137","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533137?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"SAN DIEGO and SUZHOU, China, Sept.  09, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a platform-driven, clinical-stage biotechnology company transforming the discovery and develop","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358564/0/en/adagene-achieves-milestone-in-collaboration-with-exelixis-for-advancement-of-safebody-antibody-drug-conjugate-candidates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4532","CRC","ADAG","EXEL","BK4080","BK4231","LU0266512127.USD","NETL","MSS","BK4113","BK4213","BK4139","LU0456854461.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664339138","title":"Adagene Posts Investor Presentation on Masked Anti-CTLA-4 Program Adg126","url":"https://stock-news.laohu8.com/highlight/detail?id=2664339138","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664339138?lang=en_us&edition=fundamental","pubTime":"2026-09-04 19:32","pubTimestamp":1788521564,"startTime":"0","endTime":"0","summary":"Adagene posts investor presentation on masked anti-CTLA-4 program ADG126Adagene published a medical research presentation outlining clinical progress for ADG126 (muzastotug), a masked anti-CTLA-4 anti","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL4mkGLm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660814072","title":"Adagene Management Attends Morgan Stanley Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2660814072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660814072?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:05","pubTimestamp":1787227501,"startTime":"0","endTime":"0","summary":"Adagene management attends Morgan Stanley global healthcare conference fireside chatAdagene management will attend three investor conferences in New York in September 2026.Meetings are scheduled at th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nNDL5qffS9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","BCDF","LU2210150020.SGD","SG9999014039.USD","SG9999014013.SGD","IE00BN0W2W23.USD","IE00BQXX3D17.EUR","BK4585","IE00BQXX3C00.GBP","LU2095319765.USD","NDAQ","SG9999014021.USD","BK4112","BK4588","BK4139","LU2210149790.SGD","SG9999014005.SGD","IE00BKPKM429.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660284362","title":"Adagene to Participate in Three Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284362","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284362?lang=en_us&edition=fundamental","pubTime":"2026-08-20 20:00","pubTimestamp":1787227200,"startTime":"0","endTime":"0","summary":"SAN DIEGO and SUZHOU, China, Aug.  20, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (Nasdaq: ADAG) a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/20/3348306/0/en/adagene-to-participate-in-three-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","LU0266512127.USD","CRC","LU0456854461.SGD","BK4139","MSS","ADAG","BK4113"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660977404","title":"Adagene Director Cuong Do Reports Purchase of ADS Worth $7,500","url":"https://stock-news.laohu8.com/highlight/detail?id=2660977404","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660977404?lang=en_us&edition=fundamental","pubTime":"2026-08-19 06:11","pubTimestamp":1787091117,"startTime":"0","endTime":"0","summary":"Adagene director Cuong Do reports purchase of ADS worth $7,500Adagene director Do Cuong V bought 2,000 American Depositary Shares at USD 3.75 each.Direct holdings rose to 2,000 ADS following the purch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL2Sd6B8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Adagene Director Cuong Do Reports Purchase of ADS Worth $7,500","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660436627","title":"Analysts Offer Insights on Healthcare Companies: Adagene (ADAG) and Natera (NTRA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660436627","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660436627?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:20","pubTimestamp":1786980007,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Adagene (ADAG) and Natera (NTRA). Adagene (ADAG) M...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-adagene-adag-and-natera-ntra-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2065169927.USD","LU0128526141.USD","LU0345770993.USD","LU2065170008.USD","LU2065731478.USD","LU2065171402.SGD","BK4588","LU2065171311.SGD","ADAG","LU0029874061.USD","HCSG","LU0053671581.USD","NTRA","XBI","LU1064131342.USD","LU0963586101.USD","XLV","LU2324357040.USD","HELX","LABU","LU2264538146.SGD","BK4581","LU0345770308.USD","GNOM","BK4139","LU0106261612.USD","LU1988902786.USD","BK4137","BK4585","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659315159","title":"Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2659315159","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659315159?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:10","pubTimestamp":1786619422,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Monte Rosa Therapeutics (GLUE), Mineralys Therapeuti...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-monte-rosa-therapeutics-glue-mineralys-therapeutics-inc-mlys-and-adagene-adag-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","GLUE","XBI","XLV","BK4137","BK4539","LABU","LU0128526141.USD","MLYS","ADAG","LU0029874061.USD","BK4585","BK4581","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659990126","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2659990126","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659990126?lang=en_us&edition=fundamental","pubTime":"2026-08-13 01:20","pubTimestamp":1786555206,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Orchestra BioMed Holdings (OBIO) and Adagene (ADAG) ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-297?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-297?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ADAG","BK4139","OBIO","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974198","title":"Adagene FY26 H1 Net Loss Widens to US$ 16.4 Million; Revenue Turns to US$ 1.6 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974198","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974198?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:38","pubTimestamp":1786534726,"startTime":"0","endTime":"0","summary":"Adagene FY26 H1 net loss widens to US$ 16.4 million; revenue turns to US$ 1.6 millionAdagene posted a GAAP net loss attributable to shareholders of US$16.4 million for the six months ended June 30, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDLCq3yn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","BK4588","LU2095319765.USD","BK4112","SG9999014021.USD","SG9999014013.SGD","LU2210150020.SGD","LU0314104364.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014005.SGD","ADAG","BCDF","NDAQ","BK4139","BK4585","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658097467","title":"Adagene H1 Adj. EPS $(0.20) Misses $(0.10) Estimate, Sales $1.620M","url":"https://stock-news.laohu8.com/highlight/detail?id=2658097467","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658097467?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:33","pubTimestamp":1786534408,"startTime":"0","endTime":"0","summary":"Adagene (NASDAQ:ADAG) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.10) by 100 percent. This is a 5.26 percent decrease over losses of $(0.19) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61137629/adagene-h1-adj-eps-0-20-misses-0-10-estimate-sales-1-620m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADAG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658749839","title":"Press Release: Adagene Reports Six Months 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658749839","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658749839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:30","pubTimestamp":1786534200,"startTime":"0","endTime":"0","summary":"patients that have been treated with a muzastotug dose of either 10 mg/kg. -- In the combined 10 mg/kg cohorts, muzastotug achieved an overall","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","ADAG","COAL","BK4006","BK4022","BK4195","PFS","HCC","ORR","R","BK4139","BK4232"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.1138},{"period":"1month","weight":-0.1966},{"period":"3month","weight":-0.0866},{"period":"6month","weight":-0.2082},{"period":"1year","weight":0.308},{"period":"ytd","weight":0.7302}],"compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0138},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1512},{"period":"1year","weight":0.1723},{"period":"ytd","weight":0.118}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Their platform is designed to generate therapeutic antibody candidates with unique functional epitopes and species cross-reactivity. These features enable their novel drug discovery strategy to advance from lead identification through vigorous preclinical modeling to biomarker-guided mono- and combination immunotherapy development in clinical settings. They have pioneered a dynamic interface design to harness the conformational diversity of antibodies, which enlarges epitope sampling of a given drug target for differentiated therapeutic antibody development. Their platform is designed to enable the rapid development of precision immunotherapy candidates, through the identification of predictive biomarkers for patient stratification and preselection.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.330237},{"month":2,"riseRate":0.4,"avgChangeRate":-0.074707},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.132812},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.082401},{"month":5,"riseRate":0.666667,"avgChangeRate":0.056675},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.004737},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.062128},{"month":8,"riseRate":0.5,"avgChangeRate":0.001506},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.075102},{"month":10,"riseRate":0.2,"avgChangeRate":-0.090108},{"month":11,"riseRate":0.6,"avgChangeRate":0.034268},{"month":12,"riseRate":0.4,"avgChangeRate":0.020923}],"exchange":"NASDAQ","name":"Adagene","nameEN":"Adagene","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Adagene(ADAG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Adagene,ADAG,Adagene股票,Adagene股票老虎,Adagene股票老虎国际,Adagene行情,Adagene股票行情,Adagene股价,Adagene股市,Adagene股票价格,Adagene股票交易,Adagene股票购买,Adagene股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adagene(ADAG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Adagene(ADAG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction